About Qualtra Pharmaceuticals Private Limited
Data last updated:
Qualtra Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 August 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC182601. Its GSTIN is 07AAACQ1880F1ZK (Delhi).
The company has an authorised share capital of ₹49 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Sunita Chrungoo and Anil Kumar Pandita.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit 23 Plot # 5 Dr Sandeep Complex Sm Pitampura, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2024, the company reported a revenue of ₹52.54 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹33,257 (net margin 0.6%) and EBITDA of ₹81,210 (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 8% over five years.
The company is associated with 1 brand: Qualtra Pharmaceuticals.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website qualtrapharma.com.
Company details
Contact details
Qualtra Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is qualtrapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUnit 23 Plot # 5 Dr Sandeep Complex Sm Pitampura, New Delhi, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Qualtra Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Qualtra Pharmaceuticals operates one associated brand: Qualtra Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and services emphasizing high-quality healthcare products and adherence to global standards. | qualtrapharma.com |
Business activity
The main business activity of Qualtra Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Qualtra Pharmaceuticals Private Limited, buy the company report.
Financials of Qualtra Pharmaceuticals Private Limited
FY 2025 filings availableQualtra Pharmaceuticals Private Limited reported revenue of ₹52.54 Lakh (down 6% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years, including a 6% fall in the latest year. EBITDA rose 460% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹81,210 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33,257 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Qualtra Pharmaceuticals Private Limited, buy the company report.
Board of directors of Qualtra Pharmaceuticals Private Limited
Qualtra Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunita Chrungoo | Director | 28 Aug 2008 | 18 Years 2 Months | Current |
| Anil Kumar Pandita | Director | 28 Aug 2008 | 18 Years 2 Months | Current |
Peer comparison
Qualtra Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Allbless Pharmaceuticals Private Limited | ₹52.62 Lakh (FY 2025) | 39.0% | Ahmedabad, Gujarat, India | |||
| Ontario Organics Private Limited | ₹52.62 Lakh (FY 2019) | -23.0% | Ahmedabad, Gujarat, India | |||
| Sherwyn Pharmaceuticals Private Limited | ₹52.61 Lakh (FY 2024) | 29.0% | Hyderabad, Telangana, India | |||
| Qualtra Pharmaceuticals Private Limitedthis company | ₹52.54 Lakh (FY 2024) | ₹33,257 | 0.6% | -6.0% | New Delhi, Delhi, India |
To see the full peer comparison of Qualtra Pharmaceuticals Private Limited, buy the company report.
Auditor
Qualtra Pharmaceuticals Private Limited is audited by Ajay Shikhar Jain and Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ajay Shikhar Jain and Co | FY 2023 | 016279N |
Shareholding
The shareholding of Qualtra Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Qualtra Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Qualtra Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Qualtra Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Qualtra Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACQ1880F1ZK | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Qualtra Pharmaceuticals Private Limited, buy the company report.
Recent activity
Qualtra Pharmaceuticals Private Limited has 2 board changes on record since 2008: 2 appointments. The latest: Anil Kumar Pandita was appointed as Director on 28 Aug 2008.
Frequently asked questions
Qualtra Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 August 2008 (18+ years old) and is registered under CIN U24232DL2008PTC182601.
Qualtra Pharmaceuticals has 2 current directors:
- Sunita Chrungoo - Director
- Anil Kumar Pandita - Director
The latest financial statements of Qualtra Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Qualtra Pharmaceuticals is 07AAACQ1880F1ZK, registered in Delhi.
The CIN (Corporate Identification Number) of Qualtra Pharmaceuticals is U24232DL2008PTC182601. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Qualtra Pharmaceuticals was incorporated on 28 August 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Qualtra Pharmaceuticals by revenue are Allbless Pharmaceuticals Private Limited, Ontario Organics Private Limited, Sherwyn Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Anil Kumar Pandita was appointed as Director on 28 Aug 2008. Sunita Chrungoo was appointed as Director on 28 Aug 2008.
Qualtra Pharmaceuticals can be reached through the website qualtrapharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Qualtra Pharmaceuticals is at Unit 23 Plot # 5 Dr Sandeep Complex Sm Pitampura, New Delhi, Delhi, India – 110034.
Qualtra Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
